CORE SCIENTIFIC INC (CORZ) Fundamental Analysis & Valuation

NASDAQ:CORZ • US21874A1060

15.46 USD
+0.3 (+1.98%)
At close: Mar 10, 2026
15.7 USD
+0.24 (+1.55%)
After Hours: 3/10/2026, 8:15:39 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This CORZ fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CORZ. CORZ was compared to 277 industry peers in the Software industry. Both the profitability and financial health of CORZ have multiple concerns. CORZ is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. CORZ Profitability Analysis

1.1 Basic Checks

  • In the past year CORZ was profitable.
  • CORZ had a positive operating cash flow in the past year.
  • CORZ had negative earnings in 4 of the past 5 years.
  • CORZ had a positive operating cash flow in 4 of the past 5 years.
CORZ Yearly Net Income VS EBIT VS OCF VS FCFCORZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 -500M -1B -1.5B -2B

1.2 Ratios

  • CORZ has a Return On Assets of 20.50%. This is amongst the best in the industry. CORZ outperforms 96.75% of its industry peers.
Industry RankSector Rank
ROA 20.5%
ROE N/A
ROIC N/A
ROA(3y)-43.65%
ROA(5y)-78.95%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CORZ Yearly ROA, ROE, ROICCORZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 200 -200 400

1.3 Margins

  • CORZ has a better Profit Margin (150.85%) than 98.56% of its industry peers.
  • CORZ has a Gross Margin of 11.88%. This is amonst the worse of the industry: CORZ underperforms 85.56% of its industry peers.
  • CORZ's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 150.85%
GM 11.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y108.44%
GM growth 5Y-5.27%
CORZ Yearly Profit, Operating, Gross MarginsCORZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. CORZ Health Analysis

2.1 Basic Checks

  • CORZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CORZ has more shares outstanding than it did 1 year ago.
  • CORZ has less shares outstanding than it did 5 years ago.
  • CORZ has a better debt/assets ratio than last year.
CORZ Yearly Shares OutstandingCORZ Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
CORZ Yearly Total Debt VS Total AssetsCORZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • CORZ has an Altman-Z score of -1.67. This is a bad value and indicates that CORZ is not financially healthy and even has some risk of bankruptcy.
  • CORZ's Altman-Z score of -1.67 is on the low side compared to the rest of the industry. CORZ is outperformed by 76.90% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.67
ROIC/WACCN/A
WACC10.08%
CORZ Yearly LT Debt VS Equity VS FCFCORZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B

2.3 Liquidity

  • CORZ has a Current Ratio of 1.15. This is a normal value and indicates that CORZ is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.15, CORZ is doing worse than 68.59% of the companies in the same industry.
  • A Quick Ratio of 1.15 indicates that CORZ should not have too much problems paying its short term obligations.
  • The Quick ratio of CORZ (1.15) is worse than 67.87% of its industry peers.
Industry RankSector Rank
Current Ratio 1.15
Quick Ratio 1.15
CORZ Yearly Current Assets VS Current LiabilitesCORZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. CORZ Growth Analysis

3.1 Past

  • CORZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 107.52%, which is quite impressive.
  • CORZ shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -37.53%.
  • The Revenue has been growing by 39.53% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)107.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.67%
Revenue 1Y (TTM)-37.53%
Revenue growth 3Y-20.72%
Revenue growth 5Y39.53%
Sales Q2Q%-15.98%

3.2 Future

  • The Earnings Per Share is expected to decrease by -20.64% on average over the next years. This is quite bad
  • Based on estimates for the next years, CORZ will show a very strong growth in Revenue. The Revenue will grow by 49.04% on average per year.
EPS Next Y-70.95%
EPS Next 2Y-20.64%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year117.22%
Revenue Next 2Y84.67%
Revenue Next 3Y60.56%
Revenue Next 5Y49.04%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CORZ Yearly Revenue VS EstimatesCORZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
CORZ Yearly EPS VS EstimatesCORZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6

More info and screens

Find the best growth stocksShow best growing peers

1

4. CORZ Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 33.61, which means the current valuation is very expensive for CORZ.
  • Compared to the rest of the industry, the Price/Earnings ratio of CORZ is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Earnings ratio of 26.25, CORZ is valued a bit more expensive.
  • With a Price/Forward Earnings ratio of 115.70, CORZ can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Forward Earnings ratio as CORZ.
  • CORZ is valuated expensively when we compare the Price/Forward Earnings ratio to 24.39, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 33.61
Fwd PE 115.7
CORZ Price Earnings VS Forward Price EarningsCORZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CORZ Per share dataCORZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2 -3

4.3 Compensation for Growth

  • A cheap valuation may be justified as CORZ's earnings are expected to decrease with -20.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-20.64%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CORZ Dividend Analysis

5.1 Amount

  • No dividends for CORZ!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CORZ Fundamentals: All Metrics, Ratios and Statistics

CORE SCIENTIFIC INC

NASDAQ:CORZ (3/10/2026, 8:15:39 PM)

After market: 15.7 +0.24 (+1.55%)

15.46

+0.3 (+1.98%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-02
Earnings (Next)05-05
Inst Owners117.86%
Inst Owner Change14.58%
Ins Owners0.91%
Ins Owner Change-0.89%
Market Cap4.79B
Revenue(TTM)319.02M
Net Income(TTM)481.25M
Analysts82.4
Price Target26.95 (74.32%)
Short Float %19.69%
Short Ratio5.47
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-454.27%
Min EPS beat(2)-671.83%
Max EPS beat(2)-236.7%
EPS beat(4)2
Avg EPS beat(4)99.1%
Min EPS beat(4)-671.83%
Max EPS beat(4)1256.12%
EPS beat(8)3
Avg EPS beat(8)-1907.16%
EPS beat(12)5
Avg EPS beat(12)-1329.26%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-31.26%
Min Revenue beat(2)-35.95%
Max Revenue beat(2)-26.58%
Revenue beat(4)0
Avg Revenue beat(4)-20.31%
Min Revenue beat(4)-35.95%
Max Revenue beat(4)-6.47%
Revenue beat(8)2
Avg Revenue beat(8)-9.45%
Revenue beat(12)3
Avg Revenue beat(12)-10.18%
Revenue beat(16)5
Avg Revenue beat(16)-8.57%
PT rev (1m)0%
PT rev (3m)5.79%
EPS NQ rev (1m)-75.75%
EPS NQ rev (3m)-437%
EPS NY rev (1m)0%
EPS NY rev (3m)-61.36%
Revenue NQ rev (1m)-2.66%
Revenue NQ rev (3m)-4.37%
Revenue NY rev (1m)-0.4%
Revenue NY rev (3m)-2.27%
Valuation
Industry RankSector Rank
PE 33.61
Fwd PE 115.7
P/S 15.03
P/FCF N/A
P/OCF 17.23
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.46
EY2.98%
EPS(NY)0.13
Fwd EY0.86%
FCF(TTM)-1.45
FCFYN/A
OCF(TTM)0.9
OCFY5.8%
SpS1.03
BVpS-3.11
TBVpS-3.11
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 20.5%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 150.85%
GM 11.88%
FCFM N/A
ROA(3y)-43.65%
ROA(5y)-78.95%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y108.44%
GM growth 5Y-5.27%
F-Score4
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1057.86%
Cap/Sales 228.51%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.15
Quick Ratio 1.15
Altman-Z -1.67
F-Score4
WACC10.08%
ROIC/WACCN/A
Cap/Depr(3y)386.55%
Cap/Depr(5y)539.82%
Cap/Sales(3y)83.51%
Cap/Sales(5y)84.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)107.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.67%
EPS Next Y-70.95%
EPS Next 2Y-20.64%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-37.53%
Revenue growth 3Y-20.72%
Revenue growth 5Y39.53%
Sales Q2Q%-15.98%
Revenue Next Year117.22%
Revenue Next 2Y84.67%
Revenue Next 3Y60.56%
Revenue Next 5Y49.04%
EBIT growth 1Y-2211.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year335.19%
EBIT Next 3Y109.66%
EBIT Next 5YN/A
FCF growth 1Y-761.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y548.66%
OCF growth 3Y10.69%
OCF growth 5YN/A

CORE SCIENTIFIC INC / CORZ FAQ

Can you provide the ChartMill fundamental rating for CORE SCIENTIFIC INC?

ChartMill assigns a fundamental rating of 3 / 10 to CORZ.


Can you provide the valuation status for CORE SCIENTIFIC INC?

ChartMill assigns a valuation rating of 1 / 10 to CORE SCIENTIFIC INC (CORZ). This can be considered as Overvalued.


What is the profitability of CORZ stock?

CORE SCIENTIFIC INC (CORZ) has a profitability rating of 3 / 10.


What is the financial health of CORE SCIENTIFIC INC (CORZ) stock?

The financial health rating of CORE SCIENTIFIC INC (CORZ) is 2 / 10.